SpringerProtocols: Abstract: Assays for Cytotoxicity

Assays for Cytotoxicity

By: Anthony Meager²

Abstract

Full Text

Download PDF (126K)

Among cytokine families, the tumor necrosis factor (TNF) superfamily stands out as the one that contains several members with cytotoxic activity (1–3). The best characterized is the prototypic member TNF-α, which is cytotoxic to a range of tumor cells, but not to most types of normal cells (1,4). However, there are now known to be around 20 molecularly related members of the TNF superfamily, several of which induce programmed cell death, i.e., apoptosis, in particular types of normal and tumor cells (1–3). The nomenclature for the members of the TNF superfamily was becoming complicated; individual members were given different names, e.g., Fas ligand, CD95 ligand, APO-1 ligand, by the competing research groups involved in their discovery. Recently, a nomenclature committee has adopted and promoted a simplified naming system; each member is designated tumor necrosis factor super family, TNFSF, with a numerical suffix. Thus, for example, TNF-α becomes TNFSF2 and Fas ligand becomes TNFSF6 (see Table 1 for the full list).

Table 1 TNF Ligand and Receptor Superfamily Members ^a

Ligands	Receptors
LT-α(TNF-β)/TNFSF1	TNF-R1/TNFRSF1A & TNF-R2/TNFRSF1B
	TNF-Rrp or LT-βR/TNFRSF3
TNF-α/TNFSF2	TNF-R1/TNFRSF1A & TNF-R2/TNFRSF1B
LT-β/TNFSF3	TNF-Rrp or LT-βR/TNFRSF3
OX40.L/TNFSF4	OX40 (CD134)/TNFRSF4
CD40.L/TNFSF5	CD40/TNFRSF5
Fas.L (APO-1L)/TNFSF6	Fas (CD95)/TNFRSF6 & DcR3/M68/TR6
CD27.L (CD70)/TNFSF7	CD27/TNFRSF7
CD30.L (CD153)/TNFSF8	CD30/TNFRSF8
4-1BB.L/TNFSF9	4-1BB (CD137)/TNFRSF9
TRAIL (APO-2.L)/TNFSF10/TL2	DR4/TNFRSF10A/TR4&DR5/TNFRSF10B/TR7
	DcR1/TNFRSF10C/TR5(nonfunctional) &
	DcR2/TNFRSF10D/TR10 (nonfunctional)
	OPG/TNFRSF11B/TR1
TRANCE (OPGL)/TNFSF11/TL9	TRANCE R/TNFRSF11A & OPG/TNFRSF11B/TR1
TWEAK (LTK)/TNFSF12/TL8	TWEAK-R/TNFRSF12A/TR3
APRIL (TALL-2)/TNFSF13/TL3	TACI/TNFRSF13/TR18
BlyS (TALL-1)/TNFSF13B/TL7	TACI/TNFRSF13B/TR18, BCMA/TNFRSF17/TR19 & BAFF-R/TNFRSF13C
LIGHT/TNFSF14/TL5	TNF-Rrp (LTβR)/TNFRSF3 & HVEMTNFRSF14/TR2
VEGI/TNFSF15/TL1	DR3/TNFRSF12?/TR3?
GITRL/TNFSF18/TL6	GITR/TNFRSF18/TR11
TNF-epsilon/TNFSF?/TL3	TNFRSF?
ED1/EDA/TNFSF?/TL10	EDAR/TNFRSF?/TR17 & XEDAR/TNFRSF?/TR14
TANGO-L/TNFSF?	TANGO 129/TNFRSF20?/TR12
EMILIN/TNFSF?	TNFRSF?
TRAIN-L/TNFSF?	TRAIN-R(OAF65a/APO4/TROY)/TNFRSF19/TR15

^a Unassigned receptors:- DR6/TR9, TR13, TR16, TACI-like/HPMK140/TR20, TR12-like/HCFMV39/TR21, TR21-like/HBHMF28/TR22.

Affiliation(s): (2) Division of Immunobiology, The National Institute for Biological Standards and Control, South Mimms, Hertfordshire, UK

Book Title: Cytokine Protocols

Series: Methods in Molecular Biology | Volume: 249 | Pub. Date: Oct-08-2003 | Page Range: 135-151 | DOI: 10.1385/1-59259-667-3:135

Subject: Immunology

References

Download References

1.	Meager, A. (1998) The Molecular Biology of Cytokines. Wiley, Chichester, UK.

2.	Gravestein, L. A. and Borst, J. (1998) Tumour necrosis factor receptor family members in the immune system. Semin. Immunol. 10, 423–434.

3.	Krammer, P.H. (1999) CD95 (APO/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71, 163–210.

4.	Beyaert, R. and Fiers, W. (1998) Tumour necrosis factor and lymphotoxin, in Cytokines (Mire-Sluis, A. and Thorpe, R., eds.), Academic, San Diego and London, pp. 335–360.

5.	Black, R. A., Rauch, C. T., Kozlosky, C. J., et al. (1997) A metalloproteinase disintegrin that releases tumour necrosis factor-a from cells. Nature 385, 729–733.

6.	Moss, M. L., Jin, S-L. C, Milla, M. E., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour necrosis factor-α. Nature 385, 733–736.

7.	Meager, A., Leung, H., and Woolley, J. (1989) Assays for tumour necrosis factor and related cytokines. J. Immunol. Methods 116, 1–17.

8.	Matthews, N. and Neale, M. L. (1987) Cytotoxicity assays for tumour necrosis factor and lymphotoxin, in Lymphokines and Interferons—A Practical Approach (Clemens, M. J., Morris, A. G., and Gearing, A. J. H., eds.), IRL, Oxford, pp. 221–225.

9.	Beyaert, R. and Fiers, W. (1994) Molecular mechanisms of tumour necrosis factor-induced cytotoxicity: what we do understand and what we do not. FEBS Lett. 340, 9–16.

10.	Wong, G. H. W. and Goeddel, D.V. (1988) Induction of manganous superperoxide dismutase by tumour necrosis factor: possible protective mechanism. Science 242, 941–943.

11.	Kawaguchi, T., Takeyasu, A., Matsunoba, K., et al. (1990) Stimulation of Mn-superoxide dismutase expression by tumour necrosis factor-α: quantitative determination of Mn-SOD protein levels in TNF-resistant and sensitive cells. Biochem. Biophys. Res. Commun. 171, 1378–1386.

12.	Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251.

13.	Minn, A. J., Swain, R. E., Ma, A., and Thompson, C. B. (1998) Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv. Immunol. 70, 245–279.

14.	Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355–365.

15.	Schultz-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., and Peter, M.E. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439–459.

16.	Hopkins-Donaldson, S., Bodmer, J.-L., Boulrloud, K. B., Brognara, C. B., Tschopp, J., and Gross, N. (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells with resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60, 4315–4319.

17.	Burke, F. and Balkwill, F.R. (2000) Measurement of proliferative, cytostatic, and cytolytic activity of cytokines, in Cytokine Cell Biology: A Practical Approach (Balkwill, F. R., ed.), Oxford University Press, Oxford, pp. 1–16.

18.	Meager, A. and Gaines Das, R. E. (1994) Immunological standardisation: International collaborative study of the candidate international standards for human tumour necrosis factor alpha (hTNF-α), human tumour necrosis factor beta (hTNF-β) and murine tumour necrosis factor alpha (mTNF-α). J. Immunol. Methods 170, 1–13.

19.	Kramer, S. M. and Carver, M. E. (1986) Serum-free in vitro bioassay for the detection of tumour necrosis factor. J. Immunol. Methods 93, 201–206.

20.	Espevik, T. and Nissen-Meyer, J. (1986) A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumour necrosis factor form human monocytes. J. Immunol. Methods 95, 99–105.

21.	Klostergaard, J. (1985) A rapid extremely sensitive quantitative microassay for cytotoxic cytokines. Lymphokine Res. 4, 309–317.

22.	Smith, R. A. and Baglioni, C. (1987) The active form of tumour necrosis factor is a trimer. J. Biol. Chem. 262, 6951–6954.

23.	Niitsu, Y., Watanabe, N., Sone, H., et al. (1988) Analysis of the TNF receptor on KYM cells by binding assay and affinity cross-linking. J. Biol. Response Mod. 7, 276–282.

24.	Meager, A. (1991) A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. J. Immunol. Methods 144, 141–143.

25.	Meager, A. (1999) A tumour necrosis factor-alpha (TNF-α) sensitive adherent KYM-1D4 derived cell line: use in TNF-α cytotoxicity assays in the presence of actinomycin D. J. Immunol. Methods 227, 197–198.

26.	Caron, G., Delneste, Y., Aubry, J.-P., et al. (1999) Human NK cells constitutively express transmembrane TNFα: a functional role in NK cell-mediated cytotoxicity. Eur. J. Immunol. 29, 3588–3595.

27.	Dirks, W., Schone, S., Uphoff, C. Quentmeier, H., Pradella, S., and Drexler, H. G. (1997) Expression and function of CD95 (FAS/APO-1) in leukaemia lymphoma tumour lines. Br. J. Haematol. 96, 584–593.

28.	Thomas, W. D. and Hersey, P (1998) TNF-related apoptosis-inducing ligand (TRAIL) induces apoptois in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. 161, 2195–2200.

29.	Routes, J. M., Ryan, S., Clase, A., et al. (2000) Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165, 4522–4527.

30.	Meager, A. (1987) Quantification of interferons by anti-viral assays and their standardization, in Lymphokines and Interferons—A Practical Approach (Clemens, M. J., Morris, A. G., and Gearing, A. J. H., eds.), IRL, Oxford, pp. 129–147.

31.	Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.

32.	Buttke, T. M., McCubrey, J. A., and Owen, T. C. (1993) Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 157, 233–240.

33.	Gaines Das, R. E. and Meager, A. (1995) Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF). Biologicals 23, 285–297.

34.	Meager, A. (1998) Biological standardization of interferons and other cytokines, in Bioseparation and Bioprocessing, Vol. II. (Subramanian, G., ed.), Wiley-VCH, Weinheim, pp. 255–274.

Comments (Loading...)

Post comment/View all comments